MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	30.80M -45.3%
Revenue (ttm)	8.38M +2,006.6%
Net Income	-6.94M
EPS	-0.12
Shares Out	62.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	0.5100
Previous Close	0.4900
Day's Range	0.5100 - 0.5100
52-Week Range	0.4850 - 0.9900
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2025, MustGrow Biologics's revenue was 8.29 million, an increase of 1981.95% compared to the previous year's 398,018. Losses were -7.26 million, 48.5% more than in 2024.